Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Canakinumab
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Canakinumab 150mg powder for solution for injection vials
0802040ACAAAAAA
|
Canakinumab | Canakinumab | Malignant Disease and Immunosuppression | No data available |
|
Canakinumab 150mg/1ml inj pre-filled disposable devices
0802040ACAAACAC
|
Canakinumab | Canakinumab | Malignant Disease and Immunosuppression | No data available |
|
Canakinumab 150mg/1ml solution for injection vials
0802040ACAAABAB
|
Canakinumab | Canakinumab | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.